Evasion of Cell Senescence Leads to Medulloblastoma Progression

Autor: Lukas Tamayo-Orrego, Chia-Lun Wu, Frédéric Charron, Nicolas Bouchard, Patryk Skowron, Michael D. Taylor, Marc Remke, Ahmed Khedher, Shannon M. Swikert
Rok vydání: 2015
Předmět:
0301 basic medicine
p53
p16ink4a
Somatic cell
Cell
Loss of Heterozygosity
Kaplan-Meier Estimate
Loss of heterozygosity
Mice
CDKN2A
Cerebellum
Sonic hedgehog
Promoter Regions
Genetic

lcsh:QH301-705.5
Cellular Senescence
biology
Brain Neoplasms
Immunohistochemistry
3. Good health
Patched-1 Receptor
ptch1
medicine.anatomical_structure
Disease Progression
Senescence
endocrine system
Ultraviolet Rays
Mutation
Missense

preneoplasia
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
sonic hedgehog
medicine
Animals
Humans
Hedgehog Proteins
neoplasms
Cyclin-Dependent Kinase Inhibitor p16
Medulloblastoma
DNA Methylation
medicine.disease
Mice
Inbred C57BL

stomatognathic diseases
030104 developmental biology
PTCH1
lcsh:Biology (General)
Microscopy
Fluorescence

biology.protein
Cancer research
Tumor Suppressor Protein p53
Zdroj: Cell Reports, Vol 14, Iss 12, Pp 2925-2937 (2016)
ISSN: 2211-1247
Popis: Summary How brain tumors progress from precancerous lesions to advanced cancers is not well understood. Using Ptch1 +/− mice to study medulloblastoma progression, we found that Ptch1 loss of heterozygosity (LOH) is an early event that is associated with high levels of cell senescence in preneoplasia. In contrast, advanced tumors have evaded senescence. Remarkably, we discovered that the majority of advanced medulloblastomas display either spontaneous, somatic p53 mutations or Cdkn2a locus inactivation. Consistent with senescence evasion, these p53 mutations are always subsequent to Ptch1 LOH. Introduction of a p53 mutation prevents senescence, accelerates tumor formation, and increases medulloblastoma incidence. Altogether, our results show that evasion of senescence associated with Ptch1 LOH allows progression to advanced tumors.
Databáze: OpenAIRE